THE BRUTON'S TYROSINE KINASE INHIBITOR IBRUTINIB EXERTS IMMUNOMODULATORY ACTIVITY TOWARDS TUMOR‐INFILTRATING MACROPHAGES. (June 2017) - Ding, N.